Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1385-1392
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Figure 4 Risk score in patients with different efficacy.
A: Risk score in the non-improvement group and improvement group; B: Receiver operating characteristic curve of risk score in predicting efficacy. dP < 0.0001.
- Citation: Ma XY, Sheng YP, Yang XM, Zhang HR, Sun FY. Effects of paricalcitol combined with hemodiafiltration on bone-metabolism-related indexes in patients with diabetic nephropathy and chronic renal failure. World J Diabetes 2023; 14(9): 1385-1392
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1385.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1385